Lead Product(s) : Sodium Selenite
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Boryung Pharmaceutical Co., Ltd
Deal Size : Inapplicable
Deal Type : Inapplicable
High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral Neuropathy
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
December 17, 2019
Lead Product(s) : Sodium Selenite
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Boryung Pharmaceutical Co., Ltd
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sodium Selenite
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : BIOSYN ARZNEIMITTEL GMBH | Cardiodevice Stiftung
Deal Size : Inapplicable
Deal Type : Inapplicable
High-dose Selenium Supplementation in Patients With Left Ventricular Assist
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 21, 2015
Lead Product(s) : Sodium Selenite
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : BIOSYN ARZNEIMITTEL GMBH | Cardiodevice Stiftung
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sodium Selenite
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase III
Sponsor : BIOSYN ARZNEIMITTEL GMBH | Queen's University | RWTH Aachen University
Deal Size : Inapplicable
Deal Type : Inapplicable
SodiUm SeleniTe Adminstration IN Cardiac Surgery (SUSTAIN CSX®-Trial).
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 05, 2013
Lead Product(s) : Sodium Selenite
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase III
Sponsor : BIOSYN ARZNEIMITTEL GMBH | Queen's University | RWTH Aachen University
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
